A multicenter, randomized, partial double blind, active control, parallel clinical trial to evaluate the efficacy, safety and usability of cyclosporin ophthalmic nanoemulsion 0.05% compared with cyclosporin ophthalmic emulsion 0.05% and diquafosol ophthalmic solution 3%
Phase of Trial: Phase IV
Latest Information Update: 14 Nov 2018
At a glance
- Drugs Ciclosporin (Primary) ; Diquafosol
- Indications Dry eyes
- Focus Therapeutic Use
- Acronyms CCD study
- 06 Nov 2017 Planned number of patients changed from 240 to 227.
- 06 Nov 2017 Status changed from recruiting to completed.
- 16 Feb 2017 New trial record